Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro

Concurrent Chemoradiotherapy with a Novel Fluoropyrimidine, S-1, and Cisplatin for Locally Advanced Esophageal Cancer: Long-Term Results of a Phase II Trial

(2013) Hiroaki Iwase et al.   ONCOLOGY

Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer

(2012) J.-G. Wang et al.   BLOOD

Elevated KIAA0101 expression is a marker of recurrence in human gastric cancer

(2012) Kun Zhu et al.   CANCER SCIENCE

Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation

(2012) Lijuan Liu et al.   HEPATOLOGY

Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass

(2012) Lou K. Povlsen et al.   NATURE CELL BIOLOGY

Dual functions of DNA replication forks in checkpoint signaling and PCNA ubiquitination

(2011) Xiaohong H. Yang et al.   CELL CYCLE

KIAA0101 Is Overexpressed, and Promotes Growth and Invasion in Adrenal Cancer

(2011) Meenu Jain et al.   PLoS One

Proliferating cell nuclear antigen (PCNA)-associated KIAA0101/PAF15 protein is a cell cycle-regulated anaphase-promoting complex/cyclosome substrate

(2011) M. J. Emanuele et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Esophageal Cancer

(2010) Janet M. Torpy et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

NS5ATP9 gene regulated by NF-κB signal pathway

(2008) Kang Li et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS